|
UMPS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.577600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.678450E-01 |
| Normal-vs-Stage2 |
9.881400E-01 |
| Normal-vs-Stage3 |
7.180800E-01 |
| Normal-vs-Stage4 |
1.411200E-04 |
| Stage1-vs-Stage2 |
5.457200E-01 |
| Stage1-vs-Stage3 |
7.483800E-01 |
| Stage1-vs-Stage4 |
2.777600E-02 |
| Stage2-vs-Stage3 |
8.041000E-01 |
| Stage2-vs-Stage4 |
7.189700E-02 |
| Stage3-vs-Stage4 |
5.963600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.006400E-01 |
| Normal-vs-AfricanAmerican |
7.911600E-01 |
| Normal-vs-Asian |
9.896200E-01 |
| Caucasian-vs-AfricanAmerican |
9.275400E-01 |
| Caucasian-vs-Asian |
8.977000E-01 |
| AfricanAmerican-vs-Asian |
9.184200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.582760E-01 |
| Normal-vs-Female |
1.002990E-01 |
| Male-vs-Female |
1.051780E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.731400E-01 |
| Normal-vs-Extreme_Weight |
1.529000E-01 |
| Normal-vs-Obese |
2.867000E-01 |
| Normal-vs-Extreme_Obese |
7.618600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.307800E-01 |
| Normal_Weight-vs-Obese |
7.946800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.167600E-01 |
| Extreme_Weight-vs-Obese |
8.000400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.805200E-01 |
| Obese-vs-Extreme_Obese |
9.750200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.811600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.890000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.720200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.786220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.696200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.816000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.571800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.850400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.614600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.977400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.943600E-01 |
| Normal-VS-Type2 PRCC |
4.482800E-01 |
| Normal-VS-KIRP CIMP |
4.020400E-02 |
| Normal-VS-Unclassified PRCC |
4.385600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.776000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.103190E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.809400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.426600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.571200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.995800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.323790E-02 |
| Normal-vs-N1 |
5.073000E-01 |
| Normal-vs-N2 |
4.8406999997308E-07 |
| N0-vs-N1 |
9.984100E-02 |
| N0-vs-N2 |
4.200100E-02 |
| N1-vs-N2 |
6.770500E-02 |
|
|
